by Noah Blaine

After A 54% Run-Up Since November, Can This Medical Stock Market Leader Still Cruise Higher?

Edwards Lifesciences was first featured in the IBD 50 Stocks To Watch column in November 2018. Since then, it's smashed the S&P; 500 return.

source https://finance.yahoo.com/m/7691ca5e-92f7-3469-ae50-9766451e3982/after-a-54%25-run-up-since.html?.tsrc=rss

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.